Cathie Wood’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-64,286
Closed -$20.8M 228
2020
Q2
$20.8M Sell
64,286
-72,208
-53% -$11.6M 0.22% 60
2020
Q1
$12.2M Sell
136,494
-245,587
-64% -$15.1M 0.3% 54
2019
Q4
$15.1M Buy
382,081
+30,190
+9% +$909K 0.38% 44
2019
Q3
$8.66M Buy
351,891
+22,306
+7% +$678K 0.19% 59
2019
Q2
$11.6M Buy
329,585
+85,452
+35% +$3.39M 0.29% 48
2019
Q1
$10.9M Buy
244,133
+86,996
+55% +$4.38M 0.31% 47
2018
Q4
$7.54M Sell
157,137
-2,619
-2% -$159K 0.31% 50
2018
Q3
$10.7M Buy
159,756
+60,201
+60% +$3.35M 0.32% 57
2018
Q2
$4.68M Buy
99,555
+44,187
+80% +$2.44M 0.17% 65
2018
Q1
$3.13M Buy
55,368
+31,512
+132% +$1.71M 0.16% 71
2017
Q4
$1.18M Buy
23,856
+11,907
+100% +$738K 0.09% 89
2017
Q3
$909K Buy
11,949
+6,457
+118% +$480K 0.11% 91
2017
Q2
$517K Buy
5,492
+2,428
+79% +$208K 0.1% 81
2017
Q1
$243K Buy
3,064
+462
+18% +$36.8K 0.07% 82
2016
Q4
$217K Buy
+2,602
New +$235K 0.08% 76

Other funds holding INO

Cathie Wood's INO Position: Q3 2020 in Review

Cathie Wood sold out of Inovio Pharmaceuticals (INO) in Q3 2020, closing a stake of 64,286 shares — an estimated $20.8M sold.

Cathie Wood first reported a position in INO in Q4 2016 and held it in 15 quarters. The position peaked at $20.8M in Q2 2020. 212 funds tracked by Wall St. Rank hold INO as of Q3 2020.

  • Cathie Wood reported no remaining Inovio Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Cathie Wood sold 64,286 Inovio Pharmaceuticals shares in Q3 2020, an estimated $20.8M.
  • Cathie Wood first reported a position in Inovio Pharmaceuticals in Q4 2016 and held it in 15 quarters.
  • Cathie Wood's Inovio Pharmaceuticals position peaked at $20.8M in Q2 2020.
  • 212 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2020.

Based on ARK Investment Management's 13F filing for Q3 2020, filed 30 Oct 2020.